El pre-pack concursal se está implementando en España de manera paulatina a través de diversos protocolos y resoluciones judiciales. Ofrecemos un mapa desde el que se podrá acceder a las novedades que vayan surgiendo en este terreno.

Background

Se amplía la moratoria concursal hasta el 30 de junio de 2022

El 24 de noviembre se publicó en el Boletín Oficial del Estado (BOE) el Real Decreto-ley 27/2021, de 23 de noviembre, por el que se prorrogan determinadas medidas económicas para apoyar la recuperación. Dicha norma recoge, entre otros aspectos, la extensión, hasta 2022, de la aplicación de ciertas medidas favorables a las empresas, en materia concursal, societaria, administrativa y de avales y ayudas públicas.

Selección de las principales resoluciones sobre reestructuraciones e insolvencias.

Homologada la refinanciación del Grupo Naviera Armas

Auto del Juzgado de lo Mercantil núm. 1 de Las Palmas de Gran Canaria de 27 de octubre de 2021

Whether—and in what circumstances—a debtor should pay creditors a make-whole premium continues to be litigated in bankruptcy courts. Last week, as reported by Bloomberg, Judge Dorsey (Delaware) ruled that the debtor – Mallinckrodt Plc – did not need to pay a make whole premium to first lien lenders in order to reinstate such obligations under the debtor’s chapter 11 plan.

Partially walking back her prior pronouncements suggesting that she would rule to the contrary (which we previously wrote about here), on October 13, 2021, District Court Judge Colleen McMahon denied the U.S. Trustee’s request for an emergency stay pending appeal of the Purdue Pharma confirmation order.

On October 10, 2021, Judge Colleen McMahon of the U.S. District Court for the Southern District of New York entered a temporary restraining order, delaying implementation of Purdue Pharma’s plan of reorganization, which was confirmed by Bankruptcy Judge Robert Drain on September 17th, pending argument on the U.S.

In a somewhat unexpected development given his recent appointment to a second 14-year term a mere 5 years ago, Bankruptcy Judge Robert D. Drain of the U.S. Bankruptcy Court for the Southern District of New York announced that he intends to retire as of June 30, 2022.

On September 1, 2021, Judge Robert Drain issued a much-anticipated oral ruling approving Purdue Pharma L.P.’s plan of reorganization. The plan, which has garnered significant attention from the media, legislators, academics, and practitioners, releases current and future members of the Sackler family and many of their associates and affiliated companies – none of whom filed for bankruptcy themselves – from liability in connection with any possible harm caused by OxyContin and other opioids that Purdue Pharma manufactured and distributed.

In its August 5th, 2021 VeroBlue Farms decision,[1] the Eighth Circuit lent its voice to a growing body of criticism of the equitable mootness doctrine contending that its use to bar challenges to confirmed reorganization plans should be circumscribed.